Technology transfer
AstraZeneca has launched the production of the first targeted drug for the treatment of lung cancer – osimertinib at its enterprise in the Kaluga region.
14.09.2017AstraZeneca has launched the production of the first targeted drug for the treatment of lung cancer – osimertinib at its enterprise in the Kaluga region.
14.09.2017One of the largest innovative biotechnology companies in Russia is opening the Faculty of Molecular and Cellular Biotechnology in the Pushchino science city.
31.05.2017The 8th International School of Young Scientists "Bioinformatics and Systems Biology" has opened today at the Institute of Cytology and Genetics SB RAS.
22.08.2016The ceremony of awarding the largest (in monetary terms) scientific Breakthrough Prize was held in California.
09.11.2015Of those born in 2015 37% of girls and 27% of boys will suffer from dementia in the future. The number of cases may be higher, because in their calculations, the researchers did not take into account cases of dementia starting before the age of 60.
23.09.2015A pilot project for the introduction of an electronic personal medical book will be carried out on the basis of the Center for Hygiene and Epidemiology in Moscow.
02.06.2015Russian and American scientists – Igor Efimov and Alexander Kabanov – have been elected honorary members of the American Institute of Biomedical Engineering, part of the US National Academy of Sciences.
25.03.2015On June 22, 2008, surgeon Fyodor Uglov died in St. Petersburg at the 104th year of his life. He got into the Guinness Book of Records as the world's oldest practicing surgeon.
24.06.2008After a complaint from Facebook users, the Federal Antimonopoly Service began checking ads for dietary supplements unregistered in Russia. In advertising messages, it is positioned as a cure for cancer.
02.08.2014For example, in the diagnosis of upper respiratory tract diseases, antibodies or DNA contained in a smear from the patient's oral cavity bind to the molecules deposited on the biochip. After processing, the holes of the biochip, in which such binding occurred, begin to glow.
16.05.2008A few weeks after infection with "monkey AIDS", viral DNA or RNA could not be detected in most vaccinated monkeys, and after about six months, no traces of the virus remained in any of them.
12.09.2013Apoptosis – programmed cell death – begins with the perforation of the mitochondrial membrane due to the Bak protein.
13.05.2008The number of participants in the cluster of biological and medical technologies of the Skolkovo Foundation has now exceeded 200 companies. Half of them carry out projects in the field of cancer diagnosis and treatment.
08.07.2013Experts working out the strategy of socio-economic development of Russia until 2020 ("Strategy 2020") propose a gradual increase in the retirement age in Russia for both sexes to 63 years by 2030.
14.03.2012The development of an HIV vaccine in St. Petersburg has been temporarily suspended. The reason was the lack of funding, which has not been received from the federal center for a year.
14.02.2012According to Igor Agamirzyan, CEO of the Russian Venture Company, biomedicine is one of the priorities of the RVC funds.
21.11.2011The Savelovsky court of Moscow granted the claim of the psychotherapist Anatoly Kashpirovsky to the chief psychiatrist of the Ministry of Defense of the Russian Federation V. Shamrey and the VGTRK TV company. Shamrey claimed that Kashpirovsky was harming a significant number of people and understood this.
15.06.2011An express test for AIDS based on a saliva sample has gone on sale in China, with the help of which people can independently check themselves for the presence of an immunodeficiency virus.
11.05.2011In 2010, venture capital investment in the biotechnology industry grew steadily, but noticeably slower than in other industries.
25.01.2011Patients with one of the varieties of macular degeneration, Stargardt's disease, will become the second group in the world to receive stem cells from embryos left over from in vitro fertilization.
22.11.2010You can write to the editor at:
vm@vechnayamolodost.ruThe editors of Eternal Youth are preparing a useful and interesting mailing list. You can get it if you leave your mail.